Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.Explore and learn more about Conference Series : World's leading Event Organizer
As per available reports about Hepatitis D, OMICS International has 94 Open Access Articles,153 Conference Proceedings, 4 Conferences, 6 Journals, 64 National symposiums, are being published and organized on Hepatitis A.
Hepatitis D is also referred to as hepatitis D virus (HDV) and classified as Hepatitis delta virus, is a disease caused by a small circular enveloped RNA virus. It is one of five known hepatitis viruses: A, B, C, D, and E. HDV is considered to be a sub viral satellite because it can propagate only in the presence of the hepatitis B virus (HBV). Transmission of HDV can occur either via simultaneous infection with HBV (coinfection) or superimposed on chronic hepatitis B or hepatitis B carrier state (super infection).
OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.
Scope and Importance:
In the United States, about 2% of people have hepatitis C, with the number of new cases per year stabilized at 17,000 since 2007.The number of deaths from hepatitis C has increased to 15,800 in 2008 and by 2007 had overtaken HIV/AIDS as a cause of death in the USA. This mortality rate is expected to increase, as those infected by transfusion before HCV testing become apparent. In Europe the percentage of people with chronic infections has been estimated to be between 0.13 and 3.26%.The hepatitis C viruses cannot be spread by holding hands, sharing eating utensils, kissing, hugging, coughing, sneezing, or breastfeeding. It is a perfect platform to discuss the current discoveries and developments in the field of Hepatitis Disease prevention/Control/Treatment.
Market Analysis:
The global market for infectious disease treatments was valued at $90.4 billion in 2009. This market is expected to increase at a compound annual growth rate (CAGR) of 8.8% to reach $138 billion in 2014.The largest market share belongs to antibiotic treatments for bacterial and fungal diseases at 53% of the total infectious disease treatment market. Fungal disease treatments will experience a slightly higher compound annual growth rate (CAGR) of 6.2%, from $4.6 billion in 2009 to $6.2 billion in 2014.Viral disease treatments will have the fastest compound annual growth rate (CAGR) of 12.1%, increasing from nearly $45 billion in 2009 to $79 billion in 2014.
List of Best International Conferences:
3rd HIV/AIDS, STDs and STIs Conference
November 30-December 02, 2015 Atlanta, USA
Rare Diseases and Orphan Drugs Congress
May 12-13, 2016 Chicago, USA
4th Bacteriology and Infectious Diseases Congress
May 16-18, 2016 San Antonio, USA
2nd Retroviruses and Novel Drugs Conference
June 30-July 01, 2016 Cape Town, South Africa
2nd Infectious Diseases Congress
August 25-27, 2016 Philadelphia, USA
3rd Hepatitis and Liver Diseases Congress
October 17-19, 2016 Dubai, UAE
2nd Flu Conference
November 17-19, 2016 San Francisco, USA
6th Euro Virology Congress
March 10-12 Madrid, Spain
Conference on Bio threats & Biodefense
October 17-19, 2016 Dubai, UAE
5th Virology Congress
December7-9, 2016 Atlanta, USA
20th AIDS Conferences
August 25-27, 2016 Texas, USA
15th European AIDS Conference
August 25-27, 2016 Philadelphia, USA
Social Work and HIV/AIDS Conference
November 17-19, 2016 San Francisco, USA
Relevant Society and Associations :
1. American Association for the Study of Liver Diseases
2. European Association for the Study of the Liver
3. Agency for healthcare research and quality
4. Center for Emerging Viral Infections Research
5. Hunter Medical Research Institute
Companies:
1. Novartis
2. GlaxoSmithKline
3. Merck & Co
This page will be updated regularly.
This page was last updated on November 5, 2024
